{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:06:35Z","timestamp":1775826395257,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12253-019-00606-3","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T20:21:13Z","timestamp":1550175673000},"page":"735-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Immunohistochemical Study of PD-1\/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence"],"prefix":"10.1007","volume":"26","author":[{"given":"Tomofumi","family":"Naruse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souichi","family":"Yanamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Tsuchihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"606_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM et al (2011) Global Cancer statistics: 2011. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"606_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053415","volume":"8","author":"S Listl","year":"2013","unstructured":"Listl S, Jansen L, Stenzinger A et al (2013) Survival of patients with oral cavity cancer in Germany. PLoS One 8:e53415","journal-title":"PLoS One"},{"key":"606_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.oraloncology.2008.05.008","volume":"45","author":"SN Rogers","year":"2009","unstructured":"Rogers SN, Brown JS, Woolgar JA et al (2009) Survival following primary surgery for oral cancer. Oral Oncol 45:201\u2013211","journal-title":"Oral Oncol"},{"key":"606_CR4","unstructured":"National Comprehensive Cancer Network Clinical practice guidelines in oncology (2017) Head and neck cancers, Version 2. \nhttps:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf\/\n\n. Accessed 31th January, 2018"},{"key":"606_CR5","first-page":"189","volume":"50","author":"M Umeda","year":"2004","unstructured":"Umeda M, Komatsubara H, Ojima Y et al (2004) Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU). Kobe J Med Sci 50:189\u2013196","journal-title":"Kobe J Med Sci"},{"key":"606_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1200\/JCO.2003.06.146","volume":"21","author":"L Licitra","year":"2003","unstructured":"Licitra L, Grandi C, Guzzo M et al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327\u2013333","journal-title":"J Clin Oncol"},{"key":"606_CR7","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi K, Apetoh L, Sullivan JM et al (2010) Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 207:2187\u20132194","journal-title":"J Exp Med"},{"key":"606_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.oraloncology.2014.04.003","volume":"50","author":"DP Zandberg","year":"2014","unstructured":"Zandberg DP, Strome SE (2014) The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck. Oral Oncol 50:627\u2013632","journal-title":"Oral Oncol"},{"key":"606_CR9","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1158\/0008-5472.CAN-11-4094","volume":"72","author":"SP Kerkar","year":"2012","unstructured":"Kerkar SP, Restifo NP (2012) Cellular constituents of immune escape within the tumor microenvironment. Cancer Res 72:3125\u20133130","journal-title":"Cancer Res"},{"key":"606_CR10","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/ijo.2014.2289","volume":"44","author":"S Yanamoto","year":"2014","unstructured":"Yanamoto S, Yamada S, Takahashi H et al (2014) Expression of the cancer stem cell markers CD44v6 and ABCG2 in tongue cancer: effect of neoadjuvant chemotherapy on local recurrence. Int J Oncol 44:1153\u20131162","journal-title":"Int J Oncol"},{"key":"606_CR11","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-14-3098","volume":"75","author":"J Peng","year":"2015","unstructured":"Peng J, Hamanishi J, Matsumura N et al (2015) Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-\u03baB to foster an immunosuppressive tumor microenvironment in ovarian Cancer. Cancer Res 75:5034\u20135045","journal-title":"Cancer Res"},{"key":"606_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3322\/canjclin.55.4.242","volume":"55","author":"SG Patel","year":"2005","unstructured":"Patel SG, Shah JP (2005) TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242\u2013258","journal-title":"CA Cancer J Clin"},{"key":"606_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/path.1711660409","volume":"166","author":"M Bryne","year":"1992","unstructured":"Bryne M, Koppang HS, Lilleng R et al (1992) Malignancy grading of the deep invasive margins of oral squamous cell carcinoma has high prognostic value. J Pathol 166:375\u2013381","journal-title":"J Pathol"},{"key":"606_CR14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/hed.24217","volume":"47","author":"H Hirakawa","year":"2016","unstructured":"Hirakawa H, Hanai N, Ozawa T et al (2016) Prognostic impact of pathological response to neoadjuvant chemotherapy followed by definitive surgery in sinonasal squamous cell carcinoma. Head Neck 47:1305\u20131311","journal-title":"Head Neck"},{"key":"606_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.joms.2016.11.006","volume":"75","author":"M Troeltzsch","year":"2017","unstructured":"Troeltzsch M, Woodlock T, Pianka A et al (2017) Is there evidence for the presence and relevance of the PD-1\/PD-L1 pathway in Oral squamous cell carcinoma? Hints from an Immunohistochemical study. J Oral Maxillofac Surg 75:969\u2013977","journal-title":"J Oral Maxillofac Surg"},{"key":"606_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ijom.2018.01.004","volume":"47","author":"Y Maruse","year":"2018","unstructured":"Maruse Y, Kawano S, Jinno T et al (2018) Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 47:836\u2013845","journal-title":"Int J Oral Maxillofac Surg"},{"key":"606_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.5732\/cjc.012.10219","volume":"32","author":"B Wang","year":"2013","unstructured":"Wang B, Zhang S, Yue K, Wang X-D (2013) The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer 32:614\u2013618","journal-title":"Chin J Cancer"},{"key":"606_CR18","doi-asserted-by":"publisher","first-page":"51210","DOI":"10.18632\/oncotarget.17214","volume":"8","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Miao J, Wu H et al (2017) PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes. Oncotarget 8:51210\u201351223","journal-title":"Oncotarget"},{"key":"606_CR19","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s10147-016-0962-4","volume":"21","author":"S Saigusa","year":"2016","unstructured":"Saigusa S, Toiyama Y, Tanaka K et al (2016) Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy. Int J Clin Oncol 21:946\u2013952","journal-title":"Int J Clin Oncol"},{"key":"606_CR20","doi-asserted-by":"publisher","first-page":"52889","DOI":"10.18632\/oncotarget.17547","volume":"8","author":"T M\u00fcller","year":"2017","unstructured":"M\u00fcller T, Braun M, Dietrich D et al (2017) PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma. Oncotarget 8:52889\u201352900","journal-title":"Oncotarget"},{"key":"606_CR21","first-page":"1","volume":"10","author":"YM Lin","year":"2015","unstructured":"Lin YM, Sung WW, Hsieh MJ et al (2015) High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma. PLoS One 10:1\u201311","journal-title":"PLoS One"},{"key":"606_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/ijo.2016.3785","volume":"50","author":"M Hirai","year":"2017","unstructured":"Hirai M, Kitahara H, Kobayashi Y et al (2017) Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment. Int J Oncol 50:41\u201348","journal-title":"Int J Oncol"},{"key":"606_CR23","first-page":"31616","volume":"S0901-5027","author":"GJ Hanna","year":"2017","unstructured":"Hanna GJ, Woo SB, Li YY et al (2017) Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma. Int J Oral Maxillofac Surg pii S0901-5027:31616\u201331618","journal-title":"Int J Oral Maxillofac Surg pii"},{"key":"606_CR24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/annonc\/mdx206","volume":"28","author":"A Strati","year":"2017","unstructured":"Strati A, Koutsodontis G, Papaxoinis G, Angelidis I, Zavridou M, Economopoulou P, Kotsantis I, Avgeris M, Mazel M, Perisanidis C, Sasaki C, Alix-Panabi\u00e8res C, Lianidou E, Psyrri A (2017) Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma. Ann Oncol 28:1923\u20131933","journal-title":"Ann Oncol"},{"key":"606_CR25","doi-asserted-by":"publisher","first-page":"97920","DOI":"10.18632\/oncotarget.18542","volume":"8","author":"C-Y Ock","year":"2017","unstructured":"Ock C-Y, Kim S, Keam B, Kim S, Ahn YO, Chung EJ, Kim JH, Kim TM, Kwon SK, Jeon YK, Jung KC, Kim DW, Wu HG, Sung MW, Heo DS (2017) Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma. Oncotarget 8:97920\u201397927","journal-title":"Oncotarget"},{"key":"606_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour S, Font-Burgada J, Di Caro G et al (2015) Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521:94\u201398","journal-title":"Nature"},{"key":"606_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.oraloncology.2010.01.019","volume":"46","author":"BJM Braakhuis","year":"2010","unstructured":"Braakhuis BJM, Bloemena E, Leemans CR, Brakenhoff RH (2010) Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue. Oral Oncol 46:485\u2013491","journal-title":"Oral Oncol"},{"key":"606_CR28","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris RL, Blumenschein G, Fayette J et al (2016) Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375:1856\u20131867","journal-title":"N Engl J Med"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-019-00606-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T13:10:22Z","timestamp":1590066622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-019-00606-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1007\/s12253-019-00606-3","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"28 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures of this study involving human participants were in accordance with the the 1964 Helsinki declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}